Literature DB >> 16184431

Asp746 to glycine change may have a greater influence than Cys751 to serine change in accounting for ligand selectivity between EGFR and HER-2 at the ATP site.

Shantaram A Kamath1, John K Buolamwini.   

Abstract

We have carried out up to 8.0 ns molecular dynamics simulation on the ATP-bound complexes of EGFR and HER-2 (homology model) receptor kinase domains to explore the possible consequences of amino acid residue changes in or close to the ATP site that might provide insights for selectivity of these kinases towards ATP site inhibitors. The simulation results show the formation of a channel under Thr766 following the movement of the side chain of Gln767 away from the hinge in EGFR. In HER-2, a similar movement of Gln799 occurs, but a simultaneous movement of Arg784 towards the hinge region occurs that tends to close the channel. The movement of Arg784 in HER-2 appears to result from the absence of an anchoring residue like Asp746 in EGFR, which has been changed to Gly778 in HER-2. In EGFR, this Arg784 is held away from the hinge region by interaction with Asp746, thereby leaving the channel open. This might be an important contributory factor to differences in selectivity of the ligands between the two kinases, probably more so than the conservative change of Cys751 of EGFR to serine in HER-2 at the ATP site.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16184431     DOI: 10.1007/s10822-005-5083-5

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  11 in total

Review 1.  Chemical inhibitors of protein kinases.

Authors:  A J Bridges
Journal:  Chem Rev       Date:  2001-08       Impact factor: 60.622

Review 2.  Signalling by receptor tyrosine kinases.

Authors:  W J Fantl; D E Johnson; L T Williams
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

Review 3.  Signal transduction by receptors with tyrosine kinase activity.

Authors:  A Ullrich; J Schlessinger
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

Review 4.  Protein tyrosine kinases and cancer.

Authors:  K S Kolibaba; B J Druker
Journal:  Biochim Biophys Acta       Date:  1997-12-09

5.  Development and validation of a genetic algorithm for flexible docking.

Authors:  G Jones; P Willett; R C Glen; A R Leach; R Taylor
Journal:  J Mol Biol       Date:  1997-04-04       Impact factor: 5.469

6.  Mutation of threonine 766 in the epidermal growth factor receptor reveals a hotspot for resistance formation against selective tyrosine kinase inhibitors.

Authors:  Stephanie Blencke; Axel Ullrich; Henrik Daub
Journal:  J Biol Chem       Date:  2003-02-19       Impact factor: 5.157

7.  Receptor-guided alignment-based comparative 3D-QSAR studies of benzylidene malonitrile tyrphostins as EGFR and HER-2 kinase inhibitors.

Authors:  Shantaram Kamath; John K Buolamwini
Journal:  J Med Chem       Date:  2003-10-23       Impact factor: 7.446

8.  All-atom empirical potential for molecular modeling and dynamics studies of proteins.

Authors:  A D MacKerell; D Bashford; M Bellott; R L Dunbrack; J D Evanseck; M J Field; S Fischer; J Gao; H Guo; S Ha; D Joseph-McCarthy; L Kuchnir; K Kuczera; F T Lau; C Mattos; S Michnick; T Ngo; D T Nguyen; B Prodhom; W E Reiher; B Roux; M Schlenkrich; J C Smith; R Stote; J Straub; M Watanabe; J Wiórkiewicz-Kuczera; D Yin; M Karplus
Journal:  J Phys Chem B       Date:  1998-04-30       Impact factor: 2.991

9.  Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor.

Authors:  Jennifer Stamos; Mark X Sliwkowski; Charles Eigenbrot
Journal:  J Biol Chem       Date:  2002-08-23       Impact factor: 5.157

Review 10.  Biologic and therapeutic role of HER2 in cancer.

Authors:  Sylvie Ménard; Serenella Marja Pupa; Manuela Campiglio; Elda Tagliabue
Journal:  Oncogene       Date:  2003-09-29       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.